Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Leukemia

  Free Subscription


17.08.2026

1 Acta Haematol
1 Am J Clin Oncol
1 Am J Hematol
2 Ann Hematol
1 Biochem Pharmacol
3 Blood
11 Br J Haematol
2 Cancer
1 Cancer Lett
2 Eur J Haematol
1 Exp Cell Res
1 J Pediatr Hematol Oncol
2 Leuk Lymphoma
2 Leuk Res
4 Leukemia
2 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Haematol

  1. HAO L, Li X, Xu T, Cui Y, et al
    Predictive Value of Plasma sPECAM-1, t-PA IC, and sCLEC-2 for Early Severe Bleeding in Patients with Acute Promyelocytic Leukemia.
    Acta Haematol. 2026 Aug 14:1. doi: 10.1159.
    PubMed         Abstract available


    Am J Clin Oncol

  2. FATIMA F, Mirza A, Bhatti MI, Hussain F, et al
    Pirtobrutinib in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Systematic Review.
    Am J Clin Oncol. 2026 Aug 13. doi: 10.1097/COC.0000000000001363.
    PubMed         Abstract available


    Am J Hematol

  3. ALI A, Elsey G, Fulginiti K, Kanani-Bradley Z, et al
    Navigating Asparaginase Treatment for Patients With Acute Lymphoblastic Leukemia: US Consensus Panel Recommendations on the Role of Multidisciplinary Care.
    Am J Hematol. 2026 Aug 14. doi: 10.1002/ajh.70458.
    PubMed         Abstract available


    Ann Hematol

  4. LIU SH, Deng AN, Li HY, Tan KW, et al
    Therapeutic Advances in Adult B-cell Acute Lymphoblastic Leukemia with KMT2A Rearrangements.
    Ann Hematol. 2026;105:369.
    PubMed         Abstract available

  5. TANARIYAKUL M, Mott S, Daniels B, Yaganti A, et al
    Splicing factor mutations clearance and outcomes in clonal myeloid neoplasms: a referral center experience.
    Ann Hematol. 2026;105:367.
    PubMed         Abstract available


    Biochem Pharmacol

  6. SHU Q, Xu G, Gong W, Zhu J, et al
    NAT10 drives chemoresistance in AML through ac4C-dependent stabilization of PLEKHA4.
    Biochem Pharmacol. 2026;252:118229.
    PubMed         Abstract available


    Blood

  7. PECCATORI N, Curto A, Silvestri D, Rebellato S, et al
    Measurable Residual Disease-Dependent Unfavorable Outcomes in Pediatric PAX5-Rearranged B-Acute Lymphoblastic Leukemia.
    Blood. 2026 Aug 10:blood.2026033546. doi: 10.1182/blood.2026033546.
    PubMed         Abstract available

  8. HAKOBYAN M, Langstein J, Ramos Medina MJ, Kleinert E, et al
    Mutant IDH1 blocks neutropoiesis by repressing myeloid progenitor programs.
    Blood. 2026;148:867-881.
    PubMed         Abstract available

  9. HORNS JM, Beder T, Kunstner A, Barz MJ, et al
    IDH2 clonal hematopoiesis and IKAROS loss cooperate in a B-ALL subtype after lenalidomide therapy for multiple myeloma.
    Blood. 2026;148:856-866.
    PubMed         Abstract available


    Br J Haematol

  10. CHENG Q, Zhu Y, Sheng K, Zhou J, et al
    Long-term outcomes after allogeneic versus autologous haematopoietic stem cell transplantation for T-lymphoblastic lymphoma.
    Br J Haematol. 2026 May 24. doi: 10.1111/bjh.70581.
    PubMed         Abstract available

  11. ISHIDA H, Okamoto Y, Sakaguchi H, Arai Y, et al
    Transplantation outcomes in patients with Down syndrome-associated acute lymphoblastic leukaemia: Implications for treatment intensity and the use of novel therapies.
    Br J Haematol. 2026;209:632-641.
    PubMed         Abstract available

  12. WANG H, Xue J, Yan W, Gao Y, et al
    Identification of GSE1 as a PAX5 fusion partner and characterization of PAX5 fusion signature in B-cell acute lymphoblastic leukaemia.
    Br J Haematol. 2026;209:480-490.
    PubMed         Abstract available

  13. BOBERG E, Lubking A, Lennmyr EB, Dietrich CE, et al
    Central nervous system involvement and relapse in adult acute lymphoblastic leukaemia-a population-based analysis in 2007-2022.
    Br J Haematol. 2026;209:589-600.
    PubMed         Abstract available

  14. LI R, Yao Y, Yang D, Mao L, et al
    Optimizing treatment selection and timing of allogeneic haematopoietic stem cell transplantation in acute myeloid leukaemia with concurrent feline McDonough sarcoma (FMS)-like tyrosine kinase 3 internal tandem duplication, nucleophosmin 1 and deoxyrib
    Br J Haematol. 2026;209:642-652.
    PubMed         Abstract available

  15. JIMENEZ-MIRA C, Tovar N, Martinez-Cibrian N, Gonzalez-Calle V, et al
    Cesni-cel (ARI0002h) in ultra-high-risk multiple myeloma with plasma cell leukaemia or central nervous system involvement.
    Br J Haematol. 2026;209:610-620.
    PubMed         Abstract available

  16. CONNERTY P, Colgan JN, El-Najjar F, Henry E, et al
    The myeloid cell leukaemia-1 inhibitor MIK665 is a potent therapy in preclinical models of paediatric acute myeloid leukaemia.
    Br J Haematol. 2026;209:491-502.
    PubMed         Abstract available

  17. GUPTA G, Podolsky S, Liu N, Cheung MC, et al
    Frailty and health resource utilization in 5450 adults with acute myeloid leukaemia: A population-based study from Ontario, Canada.
    Br J Haematol. 2026;209:601-609.
    PubMed         Abstract available

  18. INFANTE JB, Aguiar E, Sa I, Marques I, et al
    Improved real-world outcomes of patients with acute promyelocytic leukaemia treated with first-line arsenic trioxide in specialized centres in Portugal through a 24/7 phone-based referral.
    Br J Haematol. 2026;209:804-808.
    PubMed         Abstract available

  19. HERMANSEN JU, Yin Y, Tjonnfjord GE, Mato AR, et al
    Evolution of the drug sensitivity landscape of chronic lymphocytic leukaemia.
    Br J Haematol. 2026;209:469-479.
    PubMed         Abstract available

  20. ITONAGA H, Fukushima T, Kato K, Muranushi H, et al
    Improvements over time in survival after post-transplant relapse of adult T-cell leukaemia/lymphoma and trends of salvage therapy in a real-world experience.
    Br J Haematol. 2026 Jun 15. doi: 10.1111/bjh.70631.
    PubMed         Abstract available


    Cancer

  21. FARHAT A, El Hajjar G, Kantarjian H, Sasaki K, et al
    Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia.
    Cancer. 2026;132:e70568.
    PubMed         Abstract available

  22. DEANGELO DJ, Avagyan A, Alfaro J, Conter V, et al
    Optimizing safety and efficacy of asparaginase and blinatumomab therapy in frontline acute lymphoblastic leukemia regimens in diverse health care settings-international expert consensus.
    Cancer. 2026;132:e70559.
    PubMed         Abstract available


    Cancer Lett

  23. WANG L, Li Y, Xie W, Li R, et al
    The Fbxw11-Dpysl2 ubiquitin axis restrains the progression of acute myeloid leukemia.
    Cancer Lett. 2026 Aug 12:218782. doi: 10.1016/j.canlet.2026.218782.
    PubMed         Abstract available


    Eur J Haematol

  24. FIORENZO S, Elsa P, Alessandro S, Mario P, et al
    Long-Term Clinical Outcomes, Adherence, Persistence, and Adverse Event Management in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib.
    Eur J Haematol. 2026 Aug 14. doi: 10.1111/ejh.70292.
    PubMed         Abstract available

  25. ALBUQUERQUE TM, Sousa AVL, Rollo G, Adriano FKMS, et al
    Surgical Aspects of Patients With Leukemic Testicular Infiltration.
    Eur J Haematol. 2026;117:543-547.
    PubMed         Abstract available


    Exp Cell Res

  26. HAO M, Bian Y, Li M, Liu T, et al
    SETD5 regulates leukemic initiation and infiltration in T-cell acute lymphoblastic leukemia.
    Exp Cell Res. 2026 Aug 13:115149. doi: 10.1016/j.yexcr.2026.115149.
    PubMed         Abstract available


    J Pediatr Hematol Oncol

  27. CUBUK E, Ghosh A, Camacho PE, Marcogliese AN, et al
    A Rare BCR::SPECC1L::ABL1 Fusion in a Pediatric Chronic Myeloid Leukemia Patient.
    J Pediatr Hematol Oncol. 2026 Aug 10. doi: 10.1097/MPH.0000000000003259.
    PubMed         Abstract available


    Leuk Lymphoma

  28. SOBON A, Iskierka-Jazdzewska E, Drozd-Sokolowska J, Pula A, et al
    Efficacy and tolerability of venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukemia - real-world analysis of Polish adult leukemia study group.
    Leuk Lymphoma. 2026 Aug 10:1-10. doi: 10.1080/10428194.2026.2690480.
    PubMed         Abstract available

  29. BRONSTEIN Y, Rokach L, Herishanu Y, Arbel R, et al
    Prognostic significance of baseline liver enzyme patterns in chronic lymphocytic leukemia: a nationwide real-world cohort study.
    Leuk Lymphoma. 2026 Aug 9:1-12. doi: 10.1080/10428194.2026.2711592.
    PubMed         Abstract available


    Leuk Res

  30. JIN M, Yu Y, Zhuang S, Ni H, et al
    Stemness-driven INTS7 overexpression links metabolic comorbidity to chemoresistance in acute myeloid leukemia with type 2 diabetes.
    Leuk Res. 2026;169:108290.
    PubMed         Abstract available

  31. TSILIMIDOS G, Bou Mjahed R, Germing U, Blum S, et al
    Dose schedule modifications of 5-azacitidine monotherapy in myelodysplastic neoplasias and chronic myelomonocytic leukaemia.
    Leuk Res. 2026;168:108283.
    PubMed         Abstract available


    Leukemia

  32. FUJITA M, Ureshino H
    Do FLT3 and KIR3DL1 converge on a common immune surveillance axis in treatment-free remission of chronic myeloid leukemia?
    Leukemia. 2026 Aug 12. doi: 10.1038/s41375-026-03113.
    PubMed        

  33. ZHAO LP, Berthon C, Fenwarth L, De Botton S, et al
    Real-world patterns of treatment intensity and prognostic model performance in older acute myeloid leukemia: insights from the French ALFA-PPP Cohort.
    Leukemia. 2026 Aug 11. doi: 10.1038/s41375-026-03110.
    PubMed        

  34. ZHANG M, Liu L, Fu S, Feng J, et al
    Correction: CD7 chimeric antigen receptor T cells in patients with relapsed or refractory CD7-positive acute myeloid leukemia.
    Leukemia. 2026 Aug 10. doi: 10.1038/s41375-026-03091.
    PubMed        

  35. SHAH P, Singhal A, Chang YC, Wang TH, et al
    BTK inhibitors are associated with a lower risk of myeloid neoplasms and non-melanoma skin cancer compared with chemoimmunotherapy in chronic lymphocytic leukemia: a propensity score-matched analysis.
    Leukemia. 2026 Aug 10. doi: 10.1038/s41375-026-03089.
    PubMed        


    PLoS One

  36. NICKLE DC
    Evaluating genetic diversity differences within a likelihood framework.
    PLoS One. 2026;21:e0356079.
    PubMed         Abstract available

  37. TRAISATHIT P, Sathitsamitphong L, Rattanathammethee T, Srikummoon P, et al
    Air pollution and mortality in acute lymphoblastic leukemia patients across different age groups in Northern Thailand (1999-2020).
    PLoS One. 2026;21:e0355856.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum